Published in Can J Cardiol on October 01, 2007
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol (2013) 1.49
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ (2010) 1.45
Hypertriglyceridemic-waist phenotype and glucose intolerance among Canadian Inuit: the International Polar Year Inuit Health Survey for Adults 2007-2008. CMAJ (2011) 1.34
Fat depots, free fatty acids, and dyslipidemia. Nutrients (2013) 1.30
Waist-to-height ratio and cardiovascular risk factors among Chinese adults in Beijing. PLoS One (2013) 1.11
Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease. Cardiovasc Diabetol (2011) 1.06
Abdominal obesity: the cholesterol of the 21st century? Can J Cardiol (2008) 1.03
Hypertriglyceridemic-waist phenotype predicts diabetes: a cohort study in Chinese urban adults. BMC Public Health (2012) 0.93
Prevalence of obesity and associated cardiovascular risk: the DARIOS study. BMC Public Health (2013) 0.93
The prevalence of metabolic syndrome according to various definitions and hypertriglyceridemic-waist in malaysian adults. Int J Prev Med (2011) 0.91
Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion. J Clin Endocrinol Metab (2008) 0.89
The "hypertriglyceridemic waist" phenotype and glucose intolerance in pregnancy. CMAJ (2010) 0.88
Hypertriglyceridemic waist might be an alternative to metabolic syndrome for predicting future diabetes mellitus. PLoS One (2013) 0.88
Increased risk of diabetes development in subjects with the hypertriglyceridemic waist phenotype: a 4-year longitudinal study. Endocrinol Metab (Seoul) (2014) 0.87
Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction. J Clin Lipidol (2012) 0.84
The association between "hypertriglyceridemic waist" and sub-clinical atherosclerosis in a multiethnic population: a cross-sectional study. Lipids Health Dis (2014) 0.84
Association between the Hypertriglyceridemic Waist Phenotype, Prediabetes, and Diabetes Mellitus in Rural Chinese Population: A Cross-Sectional Study. Int J Environ Res Public Health (2016) 0.81
Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. Eur J Pediatr (2015) 0.80
Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension. Endocrinol Metab (Seoul) (2017) 0.79
Origin and therapy for hypertriglyceridaemia in type 2 diabetes. World J Diabetes (2014) 0.79
The lipid accumulation product for the early prediction of gestational insulin resistance and glucose dysregulation. J Womens Health (Larchmt) (2013) 0.78
Utility of hypertriglyceridemic waist phenotype for predicting incident type 2 diabetes: The Isfahan Diabetes Prevention Study. J Diabetes Investig (2016) 0.78
Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families. Clin Epigenetics (2016) 0.77
New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol (2015) 0.77
Predicting Metabolic Syndrome Using the Random Forest Method. ScientificWorldJournal (2015) 0.76
Predictors of metabolic abnormalities in phenotypes that combined anthropometric indices and triglycerides. BMC Complement Altern Med (2016) 0.75
The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population. Int J Environ Res Public Health (2016) 0.75
Predicting metabolic syndrome using decision tree and support vector machine methods. ARYA Atheroscler (2016) 0.75
Cardiometabolic Risk in South Asian Inhabitants of California: Hypertriglyceridemic Waist vs Hypertriglyceridemic Body Mass Index. Ethn Dis (2016) 0.75
Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points. Diabetes Metab Syndr Obes (2017) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
The metabolic syndrome. Lancet (2005) 19.47
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Abdominal obesity and metabolic syndrome. Nature (2006) 14.20
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69
Environmental contributions to the obesity epidemic. Science (1998) 11.87
Body weight and mortality among women. N Engl J Med (1995) 11.04
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol (1994) 7.21
Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation (2003) 5.70
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet (2006) 5.67
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med (1999) 5.59
Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care (2000) 4.64
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation (2000) 3.78
Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39
Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) (2006) 3.29
Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab (2003) 3.01
Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ (2001) 2.86
Is visceral obesity the cause of the metabolic syndrome? Ann Med (2006) 2.83
The Canadian obesity epidemic, 1985-1998. CMAJ (2002) 2.60
Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol (2004) 2.49
American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract (2003) 2.42
Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr (2006) 2.36
Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation (2005) 2.30
Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med (1994) 2.28
Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA (1998) 2.28
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med (2001) 2.22
Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr (2003) 2.11
A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr (1996) 2.04
Trends in waist circumference among U.S. adults. Obes Res (2003) 2.01
Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr (2006) 1.89
Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab (2002) 1.77
Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab (2002) 1.60
Hypertriglyceridemic waist as a screening tool for CVD risk in indigenous Australian women. Ethn Dis (2003) 1.45
Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med (2006) 1.40
Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr (2005) 1.30
Dysglycaemia and risk of cardiovascular disease. Lancet (1996) 1.29
Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond) (2006) 1.15
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol (2002) 1.15
Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol (2002) 1.11
The hypertriglyceridemic waist phenotype among women. Atherosclerosis (2003) 1.04
Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb (1992) 1.04
Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes Relat Metab Disord (1996) 0.96
Prevalence of the hypertriglyceridemic waist phenotype in Iranian adolescents. Am J Prev Med (2006) 0.96
Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study). Int J Obes Relat Metab Disord (2004) 0.96
The metabolic syndrome: should current criteria influence clinical practice? Curr Opin Lipidol (2006) 0.94
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids (2006) 0.91
Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men. Atherosclerosis (2003) 0.90
Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor: the Hoorn study. Diabetes Care (2004) 0.90
The hypertriglyceridaemic waist in New Zealand Maori. Asia Pac J Clin Nutr (2004) 0.78
Features of the metabolic syndrome of "hypertriglyceridemic waist" and transplant coronary artery disease. J Heart Lung Transplant (2005) 0.77
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA (2005) 7.35
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol (2013) 5.97
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med (2015) 5.59
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol (2008) 5.19
Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med (2014) 4.86
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Pathophysiology of human visceral obesity: an update. Physiol Rev (2013) 4.41
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care (2014) 3.31
Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring) (2007) 3.23
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Job strain and risk of acute recurrent coronary heart disease events. JAMA (2007) 2.61
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol (2004) 2.50
Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation (2009) 2.49
The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep (2008) 2.30
A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation (2006) 2.17
Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation (2002) 2.17
The cardiovascular effects of peroxisome proliferator-activated receptor agonists. Am J Med (2012) 2.15
Can prolonged exercise-induced myocardial ischaemia be innocuous? Eur Heart J (2007) 2.04
High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med (2009) 2.02
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension (2009) 2.00
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care (2008) 2.00
Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. Arterioscler Thromb Vasc Biol (2008) 1.96
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ (2005) 1.86
Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med (2009) 1.85
Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension (2005) 1.83
Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia. Arterioscler Thromb Vasc Biol (2003) 1.76
Generation of priority research questions to inform conservation policy and management at a national level. Conserv Biol (2010) 1.76
Cardiologists and abdominal obesity: lost in translation? Heart (2009) 1.70
Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol (2008) 1.64
Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care (2003) 1.62
Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation (2011) 1.59
Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58
Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg (2011) 1.58
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol (2004) 1.58
Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr (2008) 1.57
Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J (2009) 1.57
Effort-reward imbalance at work and recurrent coronary heart disease events: a 4-year prospective study of post-myocardial infarction patients. Psychosom Med (2011) 1.56
Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation (2006) 1.55
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol (2007) 1.54
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). J Am Coll Cardiol (2009) 1.54
Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr (2009) 1.51
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol (2003) 1.50
Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med (2009) 1.49
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr (2002) 1.49
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry (2004) 1.49
Diabetes: Looking back at Look AHEAD--giving lifestyle a chance. Nat Rev Cardiol (2013) 1.49
Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation (2005) 1.47
Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J (2004) 1.45
Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women. Am J Clin Nutr (2011) 1.45
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ (2010) 1.45
Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy. Catheter Cardiovasc Interv (2008) 1.45
Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women. Am J Med (2003) 1.44
Impact of bariatric surgery--induced weight loss on heart rate variability. Metabolism (2007) 1.43
Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil (2003) 1.43
Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes. Clin Endocrinol (Oxf) (2011) 1.42
Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res (2003) 1.41
Elevated peak exercise systolic blood pressure is not associated with reduced exercise capacity in subjects with Type 2 diabetes. J Appl Physiol (1985) (2006) 1.41
Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses. Cardiology (2012) 1.40
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr (2003) 1.40
Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab (2008) 1.39